Fluticasone propionate
Fluticasone propionate is a pharmaceutical drug with 103 clinical trials. Currently 3 active trials ongoing. Historical success rate of 89.4%.
Success Metrics
Based on 84 completed trials
Phase Distribution
Phase Distribution
15
Early Stage
24
Mid Stage
53
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
84.8%
84 of 99 finished
15.2%
15 ended early
3
trials recruiting
103
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
A Bronchoscopy Study to Assess the Effects of Inhaled Corticosteroids on Adult Healthy Volunteers
Using a Contact Dermatitis Model With Biologic Medications to Study Skin Inflammation
Study on BI 54903 (Inhaled Corticosteroid) Administered Twice Daily Via Respimat Inhaler in Patients With Asthma Inadequately Controlled on Medium Dose Inhaled Corticosteroid (ICS).
The Effect of Inhaled Corticosteroids on Vocal Fold Nodules in Children
Cycling of Topical Steroids for Treatment of EoE (Eosinopilic Esophagitis)
Clinical Trials (103)
A Bronchoscopy Study to Assess the Effects of Inhaled Corticosteroids on Adult Healthy Volunteers
Using a Contact Dermatitis Model With Biologic Medications to Study Skin Inflammation
Study on BI 54903 (Inhaled Corticosteroid) Administered Twice Daily Via Respimat Inhaler in Patients With Asthma Inadequately Controlled on Medium Dose Inhaled Corticosteroid (ICS).
The Effect of Inhaled Corticosteroids on Vocal Fold Nodules in Children
Cycling of Topical Steroids for Treatment of EoE (Eosinopilic Esophagitis)
Factors Involved in Dymista's Superior Clinical Efficacy in the Treatment of Seasonal Allergic Rhinitis
Efficacy of Intermittent Tiotropium in Early Childhood Wheezing
Two Investigational Drugs in the Prevention of Airway Constriction Brought on by Exercise in Participants With Asthma (0476-911)
Allergic Rhinitis Combination Pharmacotherapy Efficacy Study
Study Evaluating the Safety and Tolerability of NCX 4251 for the Treatment of Acute Exacerbations of Blepharitis
Clinical Equivalence Study of Fluticasone Propionate Nasal Spray, 50 mcg/Actuation vs. Flonase in Allergic Rhinitis Patients
A Proof of Concept Study to Evaluate the Dose Response for the Systemic Benefit Risk Ratio of Inhaled Fluticasone Propionate in Chronic Obstructive Pulmonary Disease
The Causal Relation of Nasal Nitric Oxide Levels to the Severity of Chronic Rhinosinusitis and Its Inflammatory Phenotype
A Study Comparing the Efficacy of Pataday® Once Daily Relief Extra Strength to Flonase® Allergy Relief in Subjects With Allergic Conjunctivitis
Dose Finding Study on BI54903 (Inhaled Corticosteroid) Administered Twice Daily Via Respimat® Inhaler in Asthmatic Patients Inadequately Controlled on Short-acting-beta-agonist (SABA) Therapy
Study on BI 54903 (Inhaled Corticosteroid) Administered Twice Daily Via Respimat Inhaler in Patients With Asthma Inadequately Controlled on Low Dose Inhaled Corticosteroid (ICS)
Single Blind Cross-over Dose Response Study in Subjects of Two Inhalers of Salmeterol and Fluticasone Propionate
BI 671800 ED in Steroid-naive Asthmatic Patients
A Study of Montelukast (MK-0476) Compared With Fluticasone in Pediatric Participants With Chronic Asthma (MK-0476-303)
Mometasone Furoate Aqueous (MK-0887/SCH 032088) Nasal Spray vs Placebo and FLONASE® in Seasonal Allergic Rhinitis Patients (I94-001)
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 103